Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA!
UPDATE : 2018/03/30
Virginia Contract Research Organization Co., Ltd. (VCRO) has conducted and managed a Phase I cell therapy for Solid Tumor clinical trial with an array of services including clinical operation, data management, statistical analysis, CSR Writing, and GCP inspection preparation. The study was successfully completed and granted TFDA’s approval on the clinical study report. This accomplishment has significantly paved the way for our client’s new drug development journey.